Anand P Chokkalingam
7PUBLICATIONS
6CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Jul 09, 2025
Systematic Review: Incidence of Liver-Related Events in People Living With Hepatitis Delta Virus.Laura E Telep, Dominique M Roulot, Amanda W Singer
|Jun 26, 2024
Remdesivir for Treatment of COVID-19 Requiring Oxygen Support: A Cross-Study Comparison From 2 Large, Open-Label Studies.Dahlene Fusco, Ivana Malenica, Huldrych F Günthard
|Apr 26, 2022
Editorial: risk of hepatocellular carcinoma with tenofovir vs entecavir-A "knock-out" is yet to be delivered-Authors' reply.W Ray Kim, Laura E Telep, Anand P Chokkalingam
|Mar 02, 2022
Sofosbuvir and risk of estimated glomerular filtration rate decline or end-stage renal disease in patients with renal impairment.Mark Sulkowski, Laura E Telep, Massimo Colombo
|Feb 09, 2022
Risk of hepatocellular carcinoma in treatment-naïve chronic hepatitis B patients receiving tenofovir disoproxil fumarate versus entecavir in the United States.W Ray Kim, Laura E Telep, Belinda Jump
|Jun 26, 2018
Letter: direct-acting anti-viral (DAA) therapy needs strong safety and efficacy check-authors' reply.A W Singer, K R Reddy, L E Telep
Pageof 2
